Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression.

Nutrition, metabolism, and cardiovascular diseases : NMCD - 1 Feb 2015

Testa A, Mallamaci F, Leonardis D, Spoto B, Pisano A, Sanguedolce M C, Tripepi G, Zoccali C

Abstract excerpt

BACKGROUND & AIMS: We have recently reported that a polymorphism (rs734553) in a major urate transporter gene (GLUT9) is a strong predictor of incident renal events in stage 2-5 CKD patients implying that life-time exposure to high uric acid levels may be causally implicated in CKD progression. S...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Creatinine
Share to Endpoint Determination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucose Transport Proteins, Facilitative

Share to Hyperuricemia

Share to Nitric Oxide Synthase

Share to Renal Insufficiency, Chronic

Share to Serum Albumin

Share to Uric Acid

Source

Identifiers

PMID: 25435339
DOI: 10.1016/j.numecd.2014.10.016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25435339-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression.PMID 25435339Read ↗

Association of a polymorphism in a gene encoding a urate transporter with CKD progression.Semantic proximity Read ↗

Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus.Semantic proximity Read ↗

ADMA, SDMA and L-arginine/ADMA ratio but not DDAH genetic polymorphisms are reliable predictors of diabetic nephropathy progression as identified by competing risk analysis.Semantic proximity Read ↗

Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease?Semantic proximity Read ↗

Genome-wide association study of L-arginine and dimethylarginines reveals novel metabolic pathway for symmetric dimethylarginine.Semantic proximity Read ↗

GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.Semantic proximity Read ↗

Analysis of ABCG2 and other urate transporters in uric acid homeostasis in chronic kidney disease: potential role of remote sensing and signalingSemantic proximity Read ↗

A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with chronic kidney disease.Semantic proximity Read ↗

Genome-wide association study on dimethylarginines reveals novel AGXT2 variants associated with heart rate variability but not with overall mortality.Semantic proximity Read ↗

Circulating methylarginine levels and the decline in renal function in patients with chronic kidney disease are modulated by DDAH1 polymorphisms.Semantic proximity Read ↗

Sex and age interaction with genetic association of atherogenic uric acid concentrations.Semantic proximity Read ↗

Apolipoprotein E polymorphism modulation of asymmetric dimethylarginine in hypertensive patients is determined by renal function.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.